Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 7e-05 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |